Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
AML Express™
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
NeoGenomics
Type:
Laboratory Developed Test
Related tests:
‹
InVisionFirst®-Lung (1)
Early-stage NSCLC Panel
InVisionSeq™
KRAS Gene Sequencing, KRAS Exons 2-4 (includes G12C mutation) Test
Myeloid Molecular Profile
Neo Comprehensive - Myeloid Disorders Assay
Neo Comprehensive - Solid Tumor Assay
Neo Comprehensive™ - Heme Cancers
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
NexCourse®
RaDaR™ assay
InVisionFirst®-Lung (1)
Early-stage NSCLC Panel
InVisionSeq™
KRAS Gene Sequencing, KRAS Exons 2-4 (includes G12C mutation) Test
Myeloid Molecular Profile
Neo Comprehensive - Myeloid Disorders Assay
Neo Comprehensive - Solid Tumor Assay
Neo Comprehensive™ - Heme Cancers
NeoLAB® Solid Tumor Liquid Biopsy
NeoTYPE® Lung Tumor Profile
NexCourse®
RaDaR™ assay
›
Details
Evidence
News
Filter by
Latest
1m
NeoGenomics launches AML express for rapid genetic profiling of Acute Myeloid Leukemia (NeoGenomics Press Release)
"NeoGenomics, Inc...announced today the launch of AML Express, a next-generation sequencing (NGS) assay designed to provide rapid, comprehensive genetic profiling for patients with acute myeloid leukemia (AML)."
1 month ago
Launch
|
AML Express™
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login